Home  »  Companies   »  Marker Therapeutics Inc. (MRKR): Skating on Thin I...

Marker Therapeutics Inc. (MRKR): Skating on Thin Ice? We Know the Answer

Marker Therapeutics Inc. (NASDAQ:MRKR) went up by 19.70% from its latest closing price compared to the recent 1-year high of $0.67. The company’s stock price has collected 14.44% of gains in the last five trading sessions.

Is It Worth Investing in Marker Therapeutics Inc. (NASDAQ :MRKR) Right Now?

Plus, the 36-month beta value for MRKR is at 1.06.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


MRKR currently public float of 66.66M and currently shorts hold a 0.88% ratio of that float. Today, the average trading volume of MRKR was 278.04K shares.

MRKR’s Market Performance

MRKR stocks went up by 14.44% for the week, with a monthly jump of 40.75% and a quarterly performance of 2.24%, while its annual performance rate touched -33.17%. The volatility ratio for the week stands at 19.36% while the volatility levels for the past 30 days are set at 14.73% for Marker Therapeutics Inc. The simple moving average for the period of the last 20 days is 30.92% for MRKR stocks with a simple moving average of 16.09% for the last 200 days.

Analysts’ Opinion of MRKR

Many brokerage firms have already submitted their reports for MRKR stocks, with Piper Sandler repeating the rating for MRKR by listing it as a “Overweight.” The predicted price for MRKR in the upcoming period, according to Piper Sandler is $6 based on the research report published on March 25th of the previous year 2021.

Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see MRKR reach a price target of $6. The rating they have provided for MRKR stocks is “Overweight” according to the report published on March 19th, 2021.

Piper Sandler gave a rating of “Neutral” to MRKR, setting the target price at $2.50 in the report published on May 12th of the previous year.

MRKR Trading at 28.46% from the 50-Day Moving Average

After a stumble in the market that brought MRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.15% of loss for the given period.

Volatility was left at 14.73%, however, over the last 30 days, the volatility rate increased by 19.36%, as shares surge +40.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.50% upper at present.

During the last 5 trading sessions, MRKR rose by +14.44%, which changed the moving average for the period of 200-days by +2.87% in comparison to the 20-day moving average, which settled at $0.3121. In addition, Marker Therapeutics Inc. saw 50.81% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for MRKR

Current profitability levels for the company are sitting at:

  • -3179.32 for the present operating margin
  • -154.70 for the gross margin

The net margin for Marker Therapeutics Inc. stands at -3372.68. Equity return is now at value -110.00, with -66.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.56.

Is SSR Mining Inc. (SSRM) a Keeper?

SSR Mining Inc. (NASDAQ:SSRM) went down by -3.03% from its latest closing price compared to the recent 1-year high of $24.58. The company’s stock price